Phage therapy shows 77% clinical improvement against superbugs as global guidelines arrive

Doctors are increasingly turning to phage therapy, which uses viruses to destroy harmful bacteria, as antibiotic resistance grows. A Belgian study reported that more than 77% of patients showed meaningful clinical improvement. New international guidelines have been issued to support the use of personalised bacteriophage treatments. Researchers, however, stress that more studies are needed before the therapy's full potential is understood.